(Q35744024)

10 August 2017

1 reference

title

Pharmacogenetics and bipolar disorder (English)

1 reference

10 August 2017

1 reference

F Mamdani

1

1 reference

10 August 2017

I Jaitovich Groisman

series ordinal

2

1 reference

10 August 2017

M Alda

series ordinal

3

1 reference

10 August 2017

G Turecki

series ordinal

4

1 reference

10 August 2017

language of work or name

1 reference

1 January 2004

1 reference

The Pharmacogenomics Journal

10 August 2017

published in

1 reference

10 August 2017

volume

4

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

161-170

1 reference

Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Pharmacogenetics of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Second messenger systems and psychoactive drug action: focus on the phosphoinositide system and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Lithium and brain signal transduction systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

The mechanisms of action of lithium. I. Effects on serotoninergic and noradrenergic systems in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Lithium: a molecular transducer of mood-stabilization in the treatment of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

The mechanisms of action of lithium. II. Effects on adenylate cyclase activity and beta-adrenergic receptor binding in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Neural and developmental actions of lithium: a unifying hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

A common mechanism of action for three mood-stabilizing drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Unanswered questions, unknown future for one of our oldest medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Predictors of lithium treatment responsiveness in bipolar patients. A two-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Factors associated with treatment success in lithium carbonate prophylaxis. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Outcomes on lithium treatment as a tool for genetic studies in affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Phenotypic spectra of bipolar disorder in responders to lithium versus lamotrigine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Genetic mapping using haplotype, association and linkage methods suggests a locus for severe bipolar disorder (BPI) at 18q22-q23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

A molecular mechanism for the effect of lithium on development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Lithium therapy and signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Mood stabilizers, glycogen synthase kinase-3beta and cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Search for a common mechanism of mood stabilizers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Dopamine receptor D2 and D4 genes, GABA(A) alpha-1 subunit genes and response to lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Identification of three polymorphisms in the translated region of PLC-gamma1 and their investigation in lithium responsive bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Serotonin transporter gene associated with lithium prophylaxis in mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Pharmacogenetics of lithium prophylaxis in mood disorders: analysis of COMT, MAO-A, and Gbeta3 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Synthesis of serotonin by a second tryptophan hydroxylase isoform

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Genomic structure and chromosomal localization of a human myo-inositol monophosphatase gene (IMPA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Association analysis of a functional G protein beta3 subunit gene polymorphism (C825T) in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

SSRIs antidepressant activity is influenced by G beta 3 variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Signaling networks in the pathophysiology and treatment of mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

No association between chromosome-18 markers and lithiumresponsive affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

Molecular genetics of bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Mode of inheritance in mood disorder families according to fluvoxamine response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Genome-wide search for linkage of bipolar affective disorders in a very large pedigree derived from a homogeneous population in quebec points to a locus of major effect on chromosome 12q23-q24

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Getting balance: drugs for bipolar disorder share target

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

A history of substance abuse complicates remission from acute mania in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Genetic history as a predictor of lithium response in manic-depressive illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Relationship between the effectiveness of lithium therapy and family history

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Prediction of affective psychoses response to lithium prophylaxis. The role of socio-demographic, clinical, psychological and biological variables

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Mode of inheritance in families of patients with lithium-responsive affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Lithium response and genetics of affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Relationship between prophylactic effect of lithium therapy and family history of affective disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Family history of affective disorders and the significance for prophylactic effect of lithium treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Family history and symptom levels during treatment for bipolar I affective disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Mood disorders--new definitions, treatment directions, and understanding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Is response to prophylactic lithium a familial trait?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Mapping susceptibility genes for bipolar disorder: a pharmacogenetic approach based on excellent response to lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Lithium responsive bipolar disorder, unilineality, and chromosome 18: A linkage study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Seizure severity and the quality of life

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Lithium-responsive affective disorders: no association with the tyrosine hydroxylase gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

MN blood groups and bipolar disorder: evidence of genotypic association and Hardy-Weinberg disequilibrium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Evidence for a role of phospholipase C-gamma1 in the pathogenesis of bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Dopamine receptor D3 gene and response to lithium prophylaxis in mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Polyglutamine tracts: no evidence of a major role in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Tryptophan hydroxylase gene and response to lithium prophylaxis in mood disorders11This work was partially supported by the BIOMED 2 grant BMH4-CT97-2307

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Polyglutamine coding genes in bipolar disorder: lack of association with selected candidate loci

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Serotonin receptor 2A, 2C, 1A genes and response to lithium prophylaxis in mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Association and linkage studies of CRH and PENK genes in bipolar disorder: a collaborative IGSLI study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

The phospholipase C-gamma1 gene (PLCG1) and lithium-responsive bipolar disorder: re-examination of an intronic dinucleotide repeat polymorphism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

A linkage study of bipolar illness

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Evidence for an association between a G-protein beta3-gene variant with depression and response to antidepressant treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Association study of C825T polymorphism of the G-protein b3 subunit gene with schizophrenia and mood disorders

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Influence of monoamine oxidase A and serotonin receptor 2A polymorphisms in SSRI antidepressant activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Differentiation of two genetically specific types of depression by the response to anti-depressants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees

1 reference

https://api.crossref.org/works/10.1038%2FSJ.TPJ.6500245

7 January 2021

Identifiers

DOI

10.1038/SJ.TPJ.6500245

1 reference

Dimensions Publication ID

10 August 2017

1007194636

0 references

Fatcat ID

release_64w7cufnh5aabpqhkophv74t5y

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/64w7cufnh5aabpqhkophv74t5y

24 November 2022

mapped directly with Wikidata item

1 reference

reason for deprecated rank

10 August 2017

15174897

incorrect identifier value

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/64w7cufnh5aabpqhkophv74t5y

9 June 2023